Literature DB >> 15681855

Prognostic factors of clinical interest in poorly differentiated carcinomas of the thyroid.

Marco Volante1, Gianni P Cavallo, Mauro Papotti.   

Abstract

Poorly differentiated (PD) carcinomas of the thyroid represent an heterogeneous but distinct group of tumors, clinically and histopathogenetically intermediate between follicular-derived well-differentiated and anaplastic carcinomas. Although the diagnostic criteria for inclusion in the PD tumor group are far from well established, and despite controversies on nomenclature, the identification of PD carcinomas as tumors with trabecular/insular/solid (TIS) growth patterns and high-grade histopathological parameters is generally accepted. Recent data on large tumor series were focused on the recognition of clinicopathological features able to predict aggressive behavior. Patient age >45 yr, the presence of necrosis (either focal or extensive), and mitotic count >3 per 10 HPF have been found to be the most influent prognostic parameters. Therefore, as also proposed for other thyroid carcinomas (e.g., papillary carcinoma) grading of PD carcinomas on the basis of these latter parameters is encouraged to select those cases with a high risk of poor outcome.

Entities:  

Mesh:

Year:  2004        PMID: 15681855     DOI: 10.1385/ep:15:4:313

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  27 in total

1.  Poorly differentiated thyroid carcinoma--it is important.

Authors:  L A Akslen; V A LiVolsi
Journal:  Am J Surg Pathol       Date:  2000-02       Impact factor: 6.394

2.  Poorly differentiated oxyphilic (Hurthle cell) carcinomas of the thyroid.

Authors:  M Papotti; B Torchio; L Grassi; A Favero; G Bussolati
Journal:  Am J Surg Pathol       Date:  1996-06       Impact factor: 6.394

3.  Long-term outcome of patients with insular carcinoma of the thyroid: the insular histotype is an independent predictor of poor prognosis.

Authors:  Gabriella Pellegriti; Dario Giuffrida; Claudia Scollo; Riccardo Vigneri; Concetto Regalbuto; Sebastiano Squatrito; Antonino Belfiore
Journal:  Cancer       Date:  2002-11-15       Impact factor: 6.860

4.  A prognostic index for thyroid carcinoma. A study of the E.O.R.T.C. Thyroid Cancer Cooperative Group.

Authors:  D P Byar; S B Green; P Dor; E D Williams; J Colon; H A van Gilse; M Mayer; R J Sylvester; M van Glabbeke
Journal:  Eur J Cancer       Date:  1979-08       Impact factor: 9.162

5.  RET activation and clinicopathologic features in poorly differentiated thyroid tumors.

Authors:  Massimo Santoro; Mauro Papotti; Gennaro Chiappetta; Ginesa Garcia-Rostan; Marco Volante; Chaline Johnson; Robert L Camp; Francesca Pentimalli; Carmen Monaco; Agustin Herrero; Maria Luisa Carcangiu; Alfredo Fusco; Giovanni Tallini
Journal:  J Clin Endocrinol Metab       Date:  2002-01       Impact factor: 5.958

6.  Insular carcinoma: a distinct de novo entity among follicular carcinomas of the thyroid gland.

Authors:  S Pilotti; P Collini; L Mariani; M Placucci; I Bongarzone; P Vigneri; S Cipriani; F Falcetta; R Miceli; M A Pierotti; F Rilke
Journal:  Am J Surg Pathol       Date:  1997-12       Impact factor: 6.394

7.  Another dissertation on poorly differentiated carcinomas: is it really necessary?

Authors:  R H Nishiyama
Journal:  Adv Anat Pathol       Date:  1999-09       Impact factor: 3.875

8.  Papillary and follicular thyroid carcinomas with an insular component.

Authors:  R Ashfaq; F Vuitch; R Delgado; J Albores-Saavedra
Journal:  Cancer       Date:  1994-01-15       Impact factor: 6.860

9.  Poorly differentiated forms of papillary thyroid carcinoma: distinctive entities or morphological patterns?

Authors:  S Pilotti; P Collini; A Manzari; E Marubini; F Rilke
Journal:  Semin Diagn Pathol       Date:  1995-08       Impact factor: 3.464

10.  Poorly differentiated carcinomas of the thyroid with trabecular, insular, and solid patterns: a clinicopathologic study of 183 patients.

Authors:  Marco Volante; Stefania Landolfi; Luigi Chiusa; Nicola Palestini; Manuela Motta; Alessandra Codegone; Bruno Torchio; Mauro G Papotti
Journal:  Cancer       Date:  2004-03-01       Impact factor: 6.860

View more
  5 in total

Review 1.  How to define follicular thyroid carcinoma?

Authors:  Kurt Werner Schmid; Nadir Rashad Farid
Journal:  Virchows Arch       Date:  2006-02-28       Impact factor: 4.064

Review 2.  An evidence-based review of poorly differentiated thyroid cancer.

Authors:  Enoch M Sanders; Virginia A LiVolsi; James Brierley; Jennifer Shin; Gregory W Randolph
Journal:  World J Surg       Date:  2007-05       Impact factor: 3.352

3.  Applying new clinicopathological characteristics to prognostication in advanced thyroid carcinoma.

Authors:  Maria E Cabanillas; Steven I Sherman
Journal:  Endocr Relat Cancer       Date:  2012-04-10       Impact factor: 5.678

4.  Efficacy of epidermal growth factor receptor-targeted molecular therapy in anaplastic thyroid cancer cell lines.

Authors:  Y Nobuhara; N Onoda; Y Yamashita; M Yamasaki; K Ogisawa; T Takashima; T Ishikawa; K Hirakawa
Journal:  Br J Cancer       Date:  2005-03-28       Impact factor: 7.640

Review 5.  Poorly differentiated thyroid carcinoma: a clinician's perspective.

Authors:  Junyu Tong; Maomei Ruan; Yuchen Jin; Hao Fu; Lin Cheng; Qiong Luo; Zhiyan Liu; Zhongwei Lv; Libo Chen
Journal:  Eur Thyroid J       Date:  2022-03-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.